✦ LIBER ✦

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial

✍ Scribed by P.M Poortmans; H Bartelink; J.C Horiot; H Struikmans; W Van den Bogaert; A Fourquet; J.J Jager; W.J Hoogenraad; P Rodrigus; C Warlam-Rodenhuis; L Collette; M Pierart

Book ID: 118622269
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 185 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)90921-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of the boost technique on

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial

✍ Philip Poortmans; Harry Bartelink; Jean-Claude Horiot; Henk Struikmans; Walter V 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Quality assurance of the EORTC trial 228

Quality assurance of the EORTC trial 22881/10882: Boost versus no boost in breast conserving therapy

✍ G. van Tienhoven; B. J. Mijnheer; H. Bartelink; D. G. González 📂 Article 📅 1997 🏛 Springer 🌐 German ⚖ 745 KB

28 oral The EORTC “boost versus no boost

28 oral The EORTC “boost versus no boost” trial: local control and cosmesis in patients with conservative management of early breast cancer

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Impact of Pathological Characteristics o

Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

✍ Moran, M.S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The influence of patient, tumor and trea

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial

✍ Conny Vrieling; Laurence Collette; Alain Fourquet; Willem J. Hoogenraad; Jean-Cl 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

The impact of a boost dose on the local

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial

✍ H. Jones; N. Antonini; L. Collette; A. Fourquet; W.J. Hoogenraad; J.J. Jager; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB